Article

Humility: The Best Characteristic in Medicine

Author(s):

Pauline Funchain, MD, highlights how humility may be one of the best characteristics in medicine right now.

At the American Society of Clinical Oncology (ASCO) 2018 annual meeting held in Chicago, Illinois, Pauline Funchain MD, associate staff member in the Taussig Cancer Institute at the Cleveland Clinic, highlights how humility may be one of the best characteristics in medicine right now.

Interview Transcript (modified slightly for readability):

“I think medicine is so complex now, it’s not fair to expect your average primary physician, or even your average oncologist, to keep track of all the rare conditions. There may be very exciting developments that not everyone will know about because they’re rare mutational events and things like that.

I think it’s really important to be humble in medicine nowadays—to know the things you know, and [for] the things you don’t know, to make sure you’re reaching out to specialists.

It’s not about how much you or any particular person knows, it’s about getting whoever it is in front of you—a real, honest-to-goodness person who has things to do and things that they love—to make sure they keep doing those things. I would really say humility may be one of the best characteristics in medicine now.

As a super specialist, we have to also admit there are things that we can do and can’t do, and that’s why we have multidisciplinary teams so that we can defer surgical decisions to the surgeon—that kind of stuff.”

Related Videos
Christine N. Kay, MD | Image Credit: Atsena Therapeutics
Christine N. Kay, MD: Interim Data on ATSN-201 Shows Promise for XLRS | Image Credit: Vitreo Retinal Associates
Roger A. Goldberg, MD: Pooled Visual Function Data of NT-501 for MacTel | Image Credit: Bay Area Retina Associates
A panel of 3 experts on ocular diseases and conditions
Signs and Symptoms of Connective Tissue Disease
Hong-Uyen Hua, MD; Sruthi Arepalli, MD; and Peter Kaiser, MD
How Gene and Cell Therapy Is Developing in Dermatology
Joyce Teng, MD, PhD, discusses how therapeutic advances in fields like epidermolysis bullosa should progress treatment discourse in other rare dermatoses.
© 2024 MJH Life Sciences

All rights reserved.